These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26074961)

  • 1. Treatment of Primary Aldosteronism and Organ Protection.
    Catena C; Colussi G; Sechi LA
    Int J Endocrinol; 2015; 2015():597247. PubMed ID: 26074961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of primary aldosteronism: its complications and their outcomes after treatment.
    Giacchetti G; Turchi F; Boscaro M; Ronconi V
    Curr Vasc Pharmacol; 2009 Apr; 7(2):244-49. PubMed ID: 19356005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid antagonists treatment versus surgery in primary aldosteronism.
    Catena C; Colussi G; Di Fabio A; Valeri M; Marzano L; Uzzau A; Sechi LA
    Horm Metab Res; 2010 Jun; 42(6):440-5. PubMed ID: 20119883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.
    Sechi LA; Colussi G; Di Fabio A; Catena C
    Am J Hypertens; 2010 Dec; 23(12):1253-60. PubMed ID: 20706195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the surgical management of primary aldosteronism.
    Iacobone M; Citton M; Viel G; Rossi GP; Nitti D
    Gland Surg; 2015 Feb; 4(1):69-81. PubMed ID: 25713782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.
    Stowasser M; Gordon RD; Gunasekera TG; Cowley DC; Ward G; Archibald C; Smithers BM
    J Hypertens; 2003 Nov; 21(11):2149-57. PubMed ID: 14597859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mineralocorticoid receptor antagonists and renal involvement in primary aldosteronism: opening of a new era.
    Catena C; Colussi G; Sechi LA
    Eur J Endocrinol; 2013 Jan; 168(1):C1-5. PubMed ID: 23082005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary aldosteronism: A common and curable form of hypertension.
    Young WF
    Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidative stress in patients affected by primary aldosteronism.
    Petramala L; Pignatelli P; Carnevale R; Zinnamosca L; Marinelli C; Settevendemmie A; Concistrè A; Tonnarini G; De Toma G; Violi F; Letizia C
    J Hypertens; 2014 Oct; 32(10):2022-9; discussion 2029. PubMed ID: 24979305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism: diagnostic and treatment strategies.
    Mattsson C; Young WF
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):198-208; quiz, 1 p following 230. PubMed ID: 16932426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and management of primary aldosteronism: an updated review.
    Chao CT; Wu VC; Kuo CC; Lin YH; Chang CC; Chueh SJ; Wu KD; Pimenta E; Stowasser M
    Ann Med; 2013 Jun; 45(4):375-83. PubMed ID: 23701121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.
    Stavropoulos K; Papadopoulos C; Koutsampasopoulos K; Lales G; Mitas C; Doumas M
    Curr Pharm Des; 2018; 24(46):5508-5516. PubMed ID: 30854950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.
    Catena C; Colussi G; Lapenna R; Nadalini E; Chiuch A; Gianfagna P; Sechi LA
    Hypertension; 2007 Nov; 50(5):911-8. PubMed ID: 17893375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term renal outcomes in patients with primary aldosteronism.
    Sechi LA; Novello M; Lapenna R; Baroselli S; Nadalini E; Colussi GL; Catena C
    JAMA; 2006 Jun; 295(22):2638-45. PubMed ID: 16772627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary aldosteronism: management issues.
    Young WF
    Ann N Y Acad Sci; 2002 Sep; 970():61-76. PubMed ID: 12381542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial.
    Dekkers T; Prejbisz A; Kool LJS; Groenewoud HJMM; Velema M; Spiering W; Kołodziejczyk-Kruk S; Arntz M; Kądziela J; Langenhuijsen JF; Kerstens MN; van den Meiracker AH; van den Born BJ; Sweep FCGJ; Hermus ARMM; Januszewicz A; Ligthart-Naber AF; Makai P; van der Wilt GJ; Lenders JWM; Deinum J;
    Lancet Diabetes Endocrinol; 2016 Sep; 4(9):739-746. PubMed ID: 27325147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors determining cardiovascular and renal outcomes after adrenalectomy in patients with aldosterone-producing adrenal adenoma.
    Chiou TT; Chiang PH; Fuh M; Liu RT; Lee WC; Lee WC; Ng HY; Tsai YC; Chuang FR; Huang CC; Lee CT
    Tohoku J Exp Med; 2009 May; 218(1):17-24. PubMed ID: 19398869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.